NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nanose Medical

Nanose Medical

Private
NetanyaHealthcare & Life Scienceshttps://nanosemed.com/

Last Round

Grant

Jan 1, 2024

Total Funding Raised

$9.13M

Company Overview

Nanose Medical is a diagnostic equipment company that develops a portable, non-invasive sensing device designed to detect volatile biomarkers in breath for early screening of lung cancer and metabolic dysfunction-associated steatohepatitis.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Sensors, Healthcare Analytics, Clinical Trials

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

breath analysiselectronic nosenon-invasive diagnosticse-nosebreath biopsyvolatile organic compoundsVOC analysismedical AIearly disease detectionbreathalyzer diagnosticspoint-of-care testingPOC testinglung cancer screeningliver disease diagnosisnanosensorbiomarker detectiondiagnostic equipmentMASH diagnosis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nanose Medical Comps

Public and private peers based on sector, stage, and business model.

Nanose Medical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Nanose Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJan 1, 2024
GrantNov 1, 2023
GrantSep 1, 2023
GrantJan 1, 2023
SeedJun 1, 2021
Pre Seed
Nov 1, 2019

Key People

Founding team and executive leadership

Ilay Marom

Co-Founder & COO

Founding Team

Orit Marom Albeck

Co-founder And CEO

Founding Team

Omer Meroz

Chief Technology Officer, Head Of Sensors R&D

Executive Team

Nanose Medical Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Grew 50% QoQ, from 10 to 15 employees.

  • Jan 8, 2026

    Monthly visitors grew 146% MoM to 1.1K.

Nanose Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nanose Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nanose Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersNetanya
Employee Range15
Year Founded2019
Last FundingJan 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.